Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS® Growth and AUR200 Devel

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. ROIV
6. ORCL
7. QCOM
8. NVS
9. INTC
10. AZN

Go back to Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS® Growth and AUR200 Devel
(NASDAQ: AUPH) Delayed: 16.07 --0 (-0%)
Previous Close $16.07    52 Week High $5.69 
Open $16.07    52 Week Low $1.42 
Day High $16.07    P/E N/A 
Day Low $16.07    EPS $0.00 
Volume 1